Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Business conference participation

Immunic to attend June conferences

Analysis based on 10 articles · First reported Jun 10, 2026 · Last updated Jun 10, 2026

Sentiment
10
Attention
2
Articles
10
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The announcement of Immunic's participation in multiple conferences could lead to increased investor interest and potential partnerships, positively impacting Immunic's stock price. Presentations on its drug pipeline, especially IMU-856, may generate positive sentiment within the biotechnology sector.

biotechnology pharmaceuticals

Immunic, a late-stage biotechnology company, announced its participation in several investor, industry, and scientific conferences throughout June 2026. Key executives, including CEO Ockelbo-Lundgren and President Jason Tay, will engage in fireside chats and one-on-one investor meetings at the H.C. Wainwright & Co. 7th Annual Neuro Perspectives Expert Summit. Immunic's management team will also attend the Cape Town International Convention Centre 2026 for partnering activities. Gbenga Genge, Global Head of Intellectual Property, will present work on IMU-856 at the EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 Symposium. Additionally, Immunic's medical team will participate in the 12th Congress of the American Academy of Neurology (EAN). These engagements aim to enhance Immunic's visibility, attract investors, and foster collaborations for its novel oral therapies for neurologic diseases.

90 Immunic announced participation
80 Ockelbo-Lundgren participated in chat
80 Jason Tay participated in chat
70 Gbenga Genge presented work
stock
Immunic will participate in several investor, industry, and scientific conferences in June 2026 to present its pipeline and engage with investors and partners, potentially increasing its visibility and attracting investment.
Importance 100 Sentiment 10
per
Ockelbo-Lundgren, CEO of Immunic, will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit, representing Immunic.
Importance 70 Sentiment 10
per
Jason Tay, President and COO of Immunic, will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit, representing Immunic.
Importance 70 Sentiment 10
per
Jessica Breu, VP Investor Relations and Communications at Immunic, will participate in one-on-one investor meetings and serve as a contact for scheduling meetings at various conferences.
Importance 60 Sentiment 10
per
Gbenga Genge, Global Head of Intellectual Property at Immunic, will present work related to IMU-856 at the EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 Symposium.
Importance 60 Sentiment 10
priv
H.C. Wainwright & Co. is hosting the 7th Annual Neuro Perspectives Expert Summit, where Immunic executives will present.
Importance 30 Sentiment 0
oth
The EFMC-ACSMEDI Medicinal Chemistry Frontiers 2026 Symposium is a scientific conference where Immunic will present work on IMU-856.
Importance 30 Sentiment 0
ngo
The 12th Congress of the American Academy of Neurology (EAN) is a medical congress where Immunic's medical team will participate.
Importance 30 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.